Delivery Order SPE2DB20D1100-SPE2DB25FE2K1
- Not listed
- The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This firm fixed-price delivery order, valued at $3,951.86, represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,616.51 for Somatuline Depot 90 mg/0.3 ml pharmaceutical product on August 4, 2025, with completion targeted for August 25, 2025. This is a firm fixed price, non-set-aside delivery order to be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Department of Defense (DoD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceuticals. The contract, valued at $2,896.41, has an ultimate completion date of April 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a $11,233.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 90 mg/0.3 ml pharmaceutical product on August 12, 2025, with completion expected by September 3, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will...
- The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,951.86 contract is for the delivery of Somatuline Depot 120 mg/0.5 ml medication, with a period of performance through May 21, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a $21,022.20 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 60 mg/0.2 ml pharmaceutical product on August 15, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award through the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,903.74 contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a prescription medication. The order has a completion date of May 16, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- AmerisourceBergen Drug Corp was awarded a $3,951.86 firm fixed-price delivery order on August 18, 2025, for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with an ultimate completion date of September 9, 2025. The contract is unclassified as to set-aside designation and is being performed in Conshohocken, Pennsylvania. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain and represents a child contract under AmerisourceBergen's larger indefinite delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2K1Delivery Order
The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with a completion date of September 15, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Somatuline Depot is a specialty pharmaceutical used for endocrine disorder management, consistent with AmerisourceBergen's established role as a critical federal pharmaceutical distributor supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. The award demonstrates the contractor's continued capability to fulfill federal medical procurement requirements through open competition and reflects the DLA Medical Supply Chain's ongoing demand for specialized pharmaceuticals to support military healthcare operations and beneficiary populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.5k | 8/22/25 |